차세대 시퀀싱(NGS) 서비스 : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)

The global market for Next-Generation Sequencing (NGS) Services was estimated to be worth US$ 21241 million in 2024 and is forecast to a readjusted size of US$ 65046 million by 2031 with a CAGR of 16.4% during the forecast period 2025-2031.

Next-Generation Sequencing (NGS) Services refer to comprehensive genetic analysis solutions based on high-throughput sequencing platforms, enabling the detection and analysis of genomic, transcriptomic, and epigenomic information at multiple levels. By leveraging parallelized, large-scale, and high-precision sequencing, NGS dramatically improves the efficiency and accuracy of genetic data acquisition, generating massive DNA or RNA sequence datasets in a single run. These services encompass the entire workflow, including sample preparation, library construction, sequencing operations, data processing, and bioinformatics analysis, while offering customized solutions for diverse needs such as research, clinical diagnostics, drug development, agricultural breeding, and microbiology studies. With advantages in cost efficiency, data depth, and application breadth, NGS services have become an essential infrastructure and innovation driver in precision medicine, life sciences, and the biotechnology industry.

The accelerated implementation of global precision medicine strategies and continuous advancements in bioinformatics are creating vast growth opportunities for the NGS services market. Increased government funding for genomics research and clinical translation projects such as early cancer screening is driving demand expansion among hospitals, research institutions, and biopharmaceutical companies. With significant reductions in sequencing costs and faster turnaround times, NGS has transitioned from exploratory research to large-scale clinical applications, covering areas such as tumor profiling, companion diagnostics, pathogen detection, and rare disease screening. Across the value chain, deeper collaborations between platform technology providers, service operators, and downstream application sectors are accelerating the adoption of new service models and value-added applications.

Despite rapid growth, the NGS services market faces challenges such as the lack of standardized data interpretation protocols, stringent regulatory requirements for clinical applications, and compliance risks related to data security. Regulatory differences across countries and regions increase the complexity of cross-border operations. High-quality bioinformatics analysis depends on experienced technical teams and robust computing infrastructure, creating barriers to entry. Certain niche segments demand extremely high sequencing accuracy and sensitivity, requiring continuous investment in R&D and quality control. Additionally, as market competition intensifies, balancing price pressures with differentiated service capabilities has become a critical test for business sustainability and expansion.

In the coming years, downstream demand for NGS services will diversify and integrate across multiple sectors. In healthcare, personalized treatment and early disease screening will continue to expand, particularly in the precision diagnosis of cancer, infectious diseases, and genetic disorders. In the biopharmaceutical industry, NGS will play a key role in new drug target discovery, elucidating drug response mechanisms, and stratifying patients in clinical trials. Agriculture and environmental sciences will further leverage NGS for crop improvement, animal breeding, and microbiome monitoring. Meanwhile, AI-driven automated analysis and cloud-based data collaboration will drive NGS services toward higher efficiency and broader accessibility, meeting the growing need for real-time, large-scale, multidimensional genetic information in both research and industrial applications.

This report aims to provide a comprehensive presentation of the global market for Next-Generation Sequencing (NGS) Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Next-Generation Sequencing (NGS) Services by region & country, by Type, and by Application.

The Next-Generation Sequencing (NGS) Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Sequencing (NGS) Services.

Market Segmentation

By Company

• Eurofins Scientific
• Natera
• BGI
• Illumina
• Roche
• LabCorp
• Berry Genomics
• Thermo Fisher Scientific
• Macrogen
• Oxford Nanopore
• Novogene
• Pacific Biosciences
• Azenta Life Sciences

Segment by Type

• Targeted Sequencing
• Whole Exome Sequencing
• Whole Genome Sequencing

Segment by Application

• Hospitals and Clinics
• Biopharma Companies
• Academic & Research Organizations
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Next-Generation Sequencing (NGS) Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Next-Generation Sequencing (NGS) Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Next-Generation Sequencing (NGS) Services in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Next-Generation Sequencing (NGS) Services Product Introduction
• 1.2 Global Next-Generation Sequencing (NGS) Services Market Size Forecast (2020-2031)
• 1.3 Next-Generation Sequencing (NGS) Services Market Trends & Drivers
  • 1.3.1 Next-Generation Sequencing (NGS) Services Industry Trends
  • 1.3.2 Next-Generation Sequencing (NGS) Services Market Drivers & Opportunity
  • 1.3.3 Next-Generation Sequencing (NGS) Services Market Challenges
  • 1.3.4 Next-Generation Sequencing (NGS) Services Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Next-Generation Sequencing (NGS) Services Players Revenue Ranking (2024)
• 2.2 Global Next-Generation Sequencing (NGS) Services Revenue by Company (2020-2025)
• 2.3 Key Companies Next-Generation Sequencing (NGS) Services Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Next-Generation Sequencing (NGS) Services Product Offered
• 2.5 Key Companies Time to Begin Mass Production of Next-Generation Sequencing (NGS) Services
• 2.6 Next-Generation Sequencing (NGS) Services Market Competitive Analysis
  • 2.6.1 Next-Generation Sequencing (NGS) Services Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by Next-Generation Sequencing (NGS) Services Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Sequencing (NGS) Services as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Targeted Sequencing
  • 3.1.2 Whole Exome Sequencing
  • 3.1.3 Whole Genome Sequencing
• 3.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Type
  • 3.2.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Next-Generation Sequencing (NGS) Services Sales Value, by Type (2020-2031)
  • 3.2.3 Global Next-Generation Sequencing (NGS) Services Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospitals and Clinics
  • 4.1.2 Biopharma Companies
  • 4.1.3 Academic & Research Organizations
  • 4.1.4 Others
• 4.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Application
  • 4.2.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Next-Generation Sequencing (NGS) Services Sales Value, by Application (2020-2031)
  • 4.2.3 Global Next-Generation Sequencing (NGS) Services Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

• 5.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Region
  • 5.1.1 Global Next-Generation Sequencing (NGS) Services Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2020-2025)
  • 5.1.3 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (2026-2031)
  • 5.1.4 Global Next-Generation Sequencing (NGS) Services Sales Value by Region (%), (2020-2031)
• 5.2 North America
  • 5.2.1 North America Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
  • 5.2.2 North America Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031
• 5.3 Europe
  • 5.3.1 Europe Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
  • 5.3.2 Europe Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
  • 5.4.2 Asia Pacific Next-Generation Sequencing (NGS) Services Sales Value by Region (%), 2024 VS 2031
• 5.5 South America
  • 5.5.1 South America Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
  • 5.5.2 South America Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
  • 5.6.2 Middle East & Africa Next-Generation Sequencing (NGS) Services Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Next-Generation Sequencing (NGS) Services Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
• 6.3 United States
  • 6.3.1 United States Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
  • 6.3.2 United States Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
  • 6.4.2 Europe Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
  • 6.5.2 China Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
  • 6.6.2 Japan Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
  • 6.7.2 South Korea Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Next-Generation Sequencing (NGS) Services Sales Value, 2020-2031
  • 6.9.2 India Next-Generation Sequencing (NGS) Services Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Next-Generation Sequencing (NGS) Services Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Eurofins Scientific
  • 7.1.1 Eurofins Scientific Profile
  • 7.1.2 Eurofins Scientific Main Business
  • 7.1.3 Eurofins Scientific Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • 7.1.4 Eurofins Scientific Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
  • 7.1.5 Eurofins Scientific Recent Developments
• 7.2 Natera
  • 7.2.1 Natera Profile
  • 7.2.2 Natera Main Business
  • 7.2.3 Natera Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • 7.2.4 Natera Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
  • 7.2.5 Natera Recent Developments
• 7.3 BGI
  • 7.3.1 BGI Profile
  • 7.3.2 BGI Main Business
  • 7.3.3 BGI Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • 7.3.4 BGI Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
  • 7.3.5 BGI Recent Developments
• 7.4 Illumina
  • 7.4.1 Illumina Profile
  • 7.4.2 Illumina Main Business
  • 7.4.3 Illumina Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • 7.4.4 Illumina Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
  • 7.4.5 Illumina Recent Developments
• 7.5 Roche
  • 7.5.1 Roche Profile
  • 7.5.2 Roche Main Business
  • 7.5.3 Roche Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • 7.5.4 Roche Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
  • 7.5.5 Roche Recent Developments
• 7.6 LabCorp
  • 7.6.1 LabCorp Profile
  • 7.6.2 LabCorp Main Business
  • 7.6.3 LabCorp Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • 7.6.4 LabCorp Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
  • 7.6.5 LabCorp Recent Developments
• 7.7 Berry Genomics
  • 7.7.1 Berry Genomics Profile
  • 7.7.2 Berry Genomics Main Business
  • 7.7.3 Berry Genomics Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • 7.7.4 Berry Genomics Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
  • 7.7.5 Berry Genomics Recent Developments
• 7.8 Thermo Fisher Scientific
  • 7.8.1 Thermo Fisher Scientific Profile
  • 7.8.2 Thermo Fisher Scientific Main Business
  • 7.8.3 Thermo Fisher Scientific Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • 7.8.4 Thermo Fisher Scientific Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
  • 7.8.5 Thermo Fisher Scientific Recent Developments
• 7.9 Macrogen
  • 7.9.1 Macrogen Profile
  • 7.9.2 Macrogen Main Business
  • 7.9.3 Macrogen Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • 7.9.4 Macrogen Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
  • 7.9.5 Macrogen Recent Developments
• 7.10 Oxford Nanopore
  • 7.10.1 Oxford Nanopore Profile
  • 7.10.2 Oxford Nanopore Main Business
  • 7.10.3 Oxford Nanopore Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • 7.10.4 Oxford Nanopore Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
  • 7.10.5 Oxford Nanopore Recent Developments
• 7.11 Novogene
  • 7.11.1 Novogene Profile
  • 7.11.2 Novogene Main Business
  • 7.11.3 Novogene Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • 7.11.4 Novogene Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
  • 7.11.5 Novogene Recent Developments
• 7.12 Pacific Biosciences
  • 7.12.1 Pacific Biosciences Profile
  • 7.12.2 Pacific Biosciences Main Business
  • 7.12.3 Pacific Biosciences Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • 7.12.4 Pacific Biosciences Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
  • 7.12.5 Pacific Biosciences Recent Developments
• 7.13 Azenta Life Sciences
  • 7.13.1 Azenta Life Sciences Profile
  • 7.13.2 Azenta Life Sciences Main Business
  • 7.13.3 Azenta Life Sciences Next-Generation Sequencing (NGS) Services Products, Services and Solutions
  • 7.13.4 Azenta Life Sciences Next-Generation Sequencing (NGS) Services Revenue (US$ Million) & (2020-2025)
  • 7.13.5 Azenta Life Sciences Recent Developments

8 Industry Chain Analysis

• 8.1 Next-Generation Sequencing (NGS) Services Industrial Chain
• 8.2 Next-Generation Sequencing (NGS) Services Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Next-Generation Sequencing (NGS) Services Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Next-Generation Sequencing (NGS) Services Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer